Linden Thomas Advisory Services LLC Grows Stake in FONAR Co. (NASDAQ:FONR)

Linden Thomas Advisory Services LLC grew its position in FONAR Co. (NASDAQ:FONR) by 15.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,236 shares of the medical equipment provider’s stock after purchasing an additional 3,837 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in FONAR were worth $443,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. lifted its stake in shares of FONAR by 148.3% during the third quarter. JPMorgan Chase & Co. now owns 3,012 shares of the medical equipment provider’s stock worth $49,000 after buying an additional 1,799 shares during the period. Lakewood Asset Management LLC acquired a new stake in shares of FONAR during the third quarter worth $173,000. Empowered Funds LLC lifted its stake in shares of FONAR by 5.3% during the third quarter. Empowered Funds LLC now owns 18,690 shares of the medical equipment provider’s stock worth $303,000 after buying an additional 938 shares during the period. Corsair Capital Management L.P. lifted its stake in shares of FONAR by 8.8% during the third quarter. Corsair Capital Management L.P. now owns 27,972 shares of the medical equipment provider’s stock worth $453,000 after buying an additional 2,266 shares during the period. Finally, Inspire Advisors LLC lifted its stake in shares of FONAR by 21.2% during the third quarter. Inspire Advisors LLC now owns 34,342 shares of the medical equipment provider’s stock worth $556,000 after buying an additional 5,998 shares during the period. 50.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of FONAR from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 16th.

FONAR Price Performance

NASDAQ FONR opened at $16.00 on Monday. The company has a market capitalization of $101.28 million, a PE ratio of 11.43 and a beta of 1.22. The company has a fifty day moving average of $15.49 and a 200 day moving average of $16.21. FONAR Co. has a 1 year low of $14.05 and a 1 year high of $24.05.

FONAR (NASDAQ:FONR) last posted its earnings results on Tuesday, November 12th. The medical equipment provider reported $0.46 earnings per share (EPS) for the quarter. The company had revenue of $24.96 million during the quarter. FONAR had a net margin of 9.41% and a return on equity of 6.10%.

FONAR Profile

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.